These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

704 related items for PubMed ID: 28804974

  • 1. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
    Vork L, Weerts ZZRM, Mujagic Z, Kruimel JW, Hesselink MAM, Muris JWM, Keszthelyi D, Jonkers DMAE, Masclee AAM.
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804974
    [Abstract] [Full Text] [Related]

  • 2. How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors.
    Aziz I, Törnblom H, Palsson OS, Whitehead WE, Simrén M.
    Am J Gastroenterol; 2018 Jul; 113(7):1017-1025. PubMed ID: 29880963
    [Abstract] [Full Text] [Related]

  • 3. Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
    Fang XC, Fan WJ, Drossman DD, Han SM, Ke MY.
    World J Gastroenterol; 2022 Sep 07; 28(33):4861-4874. PubMed ID: 36156921
    [Abstract] [Full Text] [Related]

  • 4. Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories of bowel disorders of gut-brain interactions.
    Ghoshal UC, Rahman MM, Pratap N, Misra A, Sarker SA, Hasan M, Bangdiwala SI, Palsson OS, Sperber AD.
    Neurogastroenterol Motil; 2023 Jun 07; 35(6):e14579. PubMed ID: 37010834
    [Abstract] [Full Text] [Related]

  • 5. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
    Engsbro AL, Begtrup LM, Kjeldsen J, Larsen PV, de Muckadell OS, Jarbøl DE, Bytzer P.
    Am J Gastroenterol; 2013 Jun 07; 108(6):972-80. PubMed ID: 23419383
    [Abstract] [Full Text] [Related]

  • 6. Examination of competing diagnostic models of functional gastrointestinal disorders related to pain in children.
    Schurman JV, Karazsia BT, Friesen CA.
    Neurogastroenterol Motil; 2017 Nov 07; 29(11):. PubMed ID: 28656703
    [Abstract] [Full Text] [Related]

  • 7. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria.
    Black CJ, Yiannakou Y, Houghton LA, Ford AC.
    Clin Gastroenterol Hepatol; 2020 Feb 07; 18(2):392-398.e2. PubMed ID: 31154027
    [Abstract] [Full Text] [Related]

  • 8. The Experience Sampling Method--a new digital tool for momentary symptom assessment in IBS: an exploratory study.
    Mujagic Z, Leue C, Vork L, Lousberg R, Jonkers DM, Keszthelyi D, Hesselink MA, van Schagen TJ, van Os J, Masclee AA, Kruimel JW.
    Neurogastroenterol Motil; 2015 Sep 07; 27(9):1295-302. PubMed ID: 26100684
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the Rome IV and Rome III criteria for IBS diagnosis: A cross-sectional survey.
    Bai T, Xia J, Jiang Y, Cao H, Zhao Y, Zhang L, Wang H, Song J, Hou X.
    J Gastroenterol Hepatol; 2017 May 07; 32(5):1018-1025. PubMed ID: 27862281
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study.
    Goodoory VC, Houghton LA, Yiannakou Y, Black CJ, Ford AC.
    Clin Gastroenterol Hepatol; 2022 Mar 07; 20(3):569-577.e3. PubMed ID: 33957271
    [Abstract] [Full Text] [Related]

  • 13. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
    Mikocka-Walus A, Turnbull D, Moulding N, Wilson I, Andrews JM, Holtmann G.
    J Gastroenterol Hepatol; 2008 Jul 07; 23(7 Pt 1):1137-43. PubMed ID: 18070012
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact of Rome IV criteria on the prevalence of post-infection irritable bowel syndrome.
    Breen-Lyles M, Decuir M, Byale A, Smith K, Grover M.
    Neurogastroenterol Motil; 2023 May 07; 35(5):e14532. PubMed ID: 36633303
    [Abstract] [Full Text] [Related]

  • 17. Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.
    Lackner JM, Ma CX, Keefer L, Brenner DM, Gudleski GD, Satchidanand N, Firth R, Sitrin MD, Katz L, Krasner SS, Ballou SK, Naliboff BD, Mayer EA.
    Clin Gastroenterol Hepatol; 2013 Sep 07; 11(9):1147-57. PubMed ID: 23524278
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study].
    Maev IV, Okhlobystina OZ, Khalif IL, Andreev DN.
    Ter Arkh; 2023 Feb 24; 95(1):38-51. PubMed ID: 37167114
    [Abstract] [Full Text] [Related]

  • 20. Mixture model analysis identifies irritable bowel syndrome subgroups characterised by specific profiles of gastrointestinal, extraintestinal somatic and psychological symptoms.
    Polster A, Van Oudenhove L, Jones M, Öhman L, Törnblom H, Simrén M.
    Aliment Pharmacol Ther; 2017 Sep 24; 46(5):529-539. PubMed ID: 28671338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.